- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Almost 9.6 Million Deaths Across the Globe Were Due to Cancer: Who
Oct 04, 2019
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
Yuyu Pharma will export COVID-19 test sets from SD BIOSENSOR to the world market
Jun 18, 2020
Natera Launches Zenith Genomics for Rare Disease in US Healthcare
Mar 13, 2026
North America Anti-Viral Therapies Market Growth Focusing on Trends & Innovations During the Period Until 2027
Dec 18, 2020
New Noninvasive Nutritional Testing with Metabolomix+
Jun 25, 2020
Cellulite Treatment: What Works and What You Should Know
Feb 19, 2026
Follow us on
